Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical Outcome

1 Oct 1998

Abstract excerpt

Posttransplantation lymphoproliferative disorders (PT-LPDs) represent a heterogeneous group of Epstein-Barr virus-associated lymphoid proliferations that arise in immunosuppressed transplant recipients. Some of these lesions regress after a reduction in immunosuppressive therapy, whereas some progress despite aggressive therapy. Morphological, immunophenotypic, and immunogenotypic criteria have not been useful in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Eosinophilic Disorders and Syndromes
Share to Lymphoma Diagnosis and Treatment
Share to Viral-associated cancers and disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9746767
DOI: 10.1182/blood.v92.7.2294

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BCL-6 Gene Mutations in Posttransplantation Lymphoproliferative Disorders Predict Response to Therapy and Clinical OutcomePMID 9746767Read ↗

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disordersSemantic proximity Read ↗

Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.Semantic proximity Read ↗

Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virusSemantic proximity Read ↗

Alterations on the 5' noncoding region of the BCL-6 gene are not correlated with BCL-6 protein expression in T cell non-Hodgkin lymphomas.Semantic proximity Read ↗

Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.Semantic proximity Read ↗

Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features.Semantic proximity Read ↗

The impact of the World Health Organization classification and clonality assessment of posttransplant lymphoproliferative disorders on disease management.Semantic proximity Read ↗

The molecular genetics of post-transplantation lymphoproliferative disorders.Semantic proximity Read ↗

Post-transplant lymphoproliferative disorders: a morphologic, phenotypic and genotypic spectrum of disease.Semantic proximity Read ↗

Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.Semantic proximity Read ↗

Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?Semantic proximity Read ↗

EPSTEIN-BARR VIRUS-NEGATIVE LYMPHOPROLIFERATIVE DISORDERS IN LONG-TERM SURVIVORS AFTER HEART, KIDNEY, AND LIVER TRANSPLANT1Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.